PBH revenue falls 4.3% as Clear Eyes supply woes persist; $10.3M supplier loan written off

Filed May 14, 2026 · Period ending March 31, 2026 · Compared to 10-K May 9, 2025 · ~2 min read

Key Changes

• high

  Wrote off $10.3M supplier loan after the manufacturer discontinued operations and did not repay, a one-time charge hitting operating income.

  Risk Factors / MD&A: Other Expense verify on EDGAR →
• high

  Eye & Ear Care revenue plunged 20.6% to $126.1M (from $158.9M) due to ongoing Clear Eyes supply constraints, despite acquiring the Pillar5 manufacturing facility in December 2025.

  MD&A: Segment Revenue verify on EDGAR →
• high

  Gross margin compressed 110 basis points to 54.7% (from 55.8%), driven by the revenue decline and costs related to the Pillar5 acquisition.

  MD&A: Gross Profit verify on EDGAR →